Anti-diabetic effects of Ganoderma lucidum.

Ganoderma lucidum is a white rot fungus widely used as a tonic for the promotion of longevity and health. Extracts of G. lucidum have been recognized as an alternative adjuvant treatment for diabetes. Among the many biologically active constituents of G. lucidum, polysaccharides, proteoglycans, proteins and triterpenoids have been shown to have hypoglycemic effects. G. lucidum polysaccharides have been reported to have hypoglycemic activity by increasing plasma insulin levels and decreasing plasma sugar levels in mice. Protein tyrosine phosphatase 1B is a promising therapeutic target in diabetes, and G. lucidum proteoglycan can inhibit this enzyme in vitro. Moreover, G. lucidum triterpenoids were shown to have inhibitory activity on aldose reductase and α-glucosidase that can suppress postprandial hyperglycemia. In addition, a protein Ling Zhi-8 extracted from G. lucidum significantly decreased lymphocyte infiltration and increased the antibody detection of insulin in diabetic mice. This review summarizes most of the research about the hypoglycemic action effects of polysaccharides, proteoglycans, proteins and tritrerpenoids from G. lucidum as a guide for future research.

[1]  P. Montgomery,et al.  Acarbose: an alpha-glucosidase inhibitor. , 1996, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[2]  J. Mccormack,et al.  Pharmacological approaches to inhibit endogenous glucose production as a means of anti-diabetic therapy. , 2001, Current pharmaceutical design.

[3]  T. Asano,et al.  Increased Liver Glucose-Transporter Protein and mRNA in Streptozocin-Induced Diabetic Rats , 1990, Diabetes.

[4]  Oluwadamilola O Olaku,et al.  Herbal therapy use by cancer patients: a literature review on case reports. , 2011, European journal of cancer.

[5]  Kate E Schemmel,et al.  Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review. , 2010, Journal of diabetes and its complications.

[6]  J. Buswell,et al.  Ganoderma lucidum (Lingzhi or Reishi): A Medicinal Mushroom -- Herbal Medicine: Biomolecular and Clinical Aspects , 2011 .

[7]  H. Hsu,et al.  Reishi Protein LZ-8 Induces FOXP3+ Treg Expansion via a CD45-Dependent Signaling Pathway and Alleviates Acute Intestinal Inflammation in Mice , 2013, Evidence-based complementary and alternative medicine : eCAM.

[8]  L. Agius.  New hepatic targets for glycaemic control in diabetes. , 2007, Best practice & research. Clinical endocrinology & metabolism.

[9]  R. Kondo,et al.  Inhibition of aldose reductase in vitro by constituents of Ganoderma lucidum. , 2010, Planta medica.

[10]  S. Wachtel-Galor.  Herbal Medicine : Biomolecular and Clinical Aspects, Second Edition , 2011 .

[11]  A. Combs.  Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer. , 2010, Journal of medicinal chemistry.

[12]  J. Watanabe,et al.  Isolation and characterization of a new immunomodulatory protein, ling zhi-8 (LZ-8), from Ganoderma lucidium. , 1989, The Journal of biological chemistry.

[13]  Lan Yuan,et al.  In vitro and in vivo protective effect of Ganoderma lucidum polysaccharides on alloxan-induced pancreatic islets damage. , 2003, Life sciences.

[14]  F. Marcheselli,et al.  Apoptosis in human aortic endothelial cells induced by hyperglycemic condition involves mitochondrial depolarization and is prevented by N-acetyl-L-cysteine. , 2002, Metabolism: clinical and experimental.

[15]  Ju-Sheng Zheng,et al.  Ganoderma lucidum polysaccharides exert anti-hyperglycemic effect on streptozotocin-induced diabetic rats through affecting β-cells. , 2012, Combinatorial chemistry & high throughput screening.

[16]  R. Kondo,et al.  Structure-activity relationships of lanostane-type triterpenoids from Ganoderma lingzhi as α-glucosidase inhibitors. , 2013, Bioorganic & medicinal chemistry letters.

[17]  B. Tomlinson,et al.  Ganoderma lucidum ("Lingzhi"), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. , 2004, The British journal of nutrition.

[18]  Jin-jian Lu,et al.  Anti-cancer properties of triterpenoids isolated from Ganoderma lucidum – a review , 2013, Expert opinion on investigational drugs.

[19]  B. Schwippert,et al.  Induction of apoptosis by high proinsulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species , 1998, Diabetologia.

[20]  P. Zhou,et al.  Hypoglycemic effect and mechanism of a proteoglycan from ganoderma lucidum on streptozotocin-induced type 2 diabetic rats. , 2012, European review for medical and pharmacological sciences.

[21]  D. Miranda-Saavedra,et al.  PTP1B: A simple enzyme for a complex world , 2013, Critical reviews in biochemistry and molecular biology.

[22]  P. Li,et al.  Triterpenoids from Ganoderma lucidum and their cytotoxic activities , 2013, Natural product research.

[23]  P. Zhou,et al.  Antidiabetic, Antihyperlipidemic and Antioxidant Activities of a Novel Proteoglycan from Ganoderma Lucidum Fruiting Bodies on db/db Mice and the Possible Mechanism , 2013, PloS one.

[24]  Kaori Takahashi,et al.  The inhibitory effect on aldose reductase by an extract of Ganoderma lucidum , 2009, Phytotherapy research : PTR.

[25]  M. Shiao.  Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions. , 2003, Chemical record.

[26]  G. King,et al.  Effects of Diabetes and Insulin Resistance on Endothelial Functions , 2005 .

[27]  Bojana Boh,et al.  Ganoderma lucidum and its pharmaceutically active compounds. , 2007, Biotechnology annual review.

[28]  K. Mizumoto,et al.  An immunomodulating protein, Ling Zhi-8 (LZ-8) prevents insulitis in non-obese diabetic mice , 1990, Diabetologia.

[29]  K. Gabbay,et al.  Hyperglycemia, polyol metabolism, and complications of diabetes mellitus. , 1975, Annual review of medicine.

[30]  Yiming Zhang,et al.  Antihyperglycemic Effect of Ganoderma Lucidum Polysaccharides on Streptozotocin-Induced Diabetic Mice , 2011, International journal of molecular sciences.

[31]  R. Kondo,et al.  Structure-activity relationship for inhibition of 5alpha-reductase by triterpenoids isolated from Ganoderma lucidum. , 2006, Bioorganic & medicinal chemistry.

[32]  Qingping Wu,et al.  Hypoglycemic effects of Ganoderma lucidum polysaccharides in type 2 diabetic mice , 2012, Archives of pharmacal research.

[33]  R. Kondo,et al.  Ganoderol B: a potent α-glucosidase inhibitor isolated from the fruiting body of Ganoderma lucidum. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[34]  G. Nuovo,et al.  Regression of Gastric Large B-Cell Lymphoma Accompanied by a Florid Lymphoma-like T-Cell Reaction: Immunomodulatory Effect of Ganoderma lucidum (Lingzhi)? , 2007, International journal of surgical pathology.

[35]  R. Kondo,et al.  Structure-activity relationships of ganoderma acids from Ganoderma lucidum as aldose reductase inhibitors. , 2011, Bioorganic & medicinal chemistry letters.

[36]  A. Bhatnagar,et al.  Aldose reductase: congenial and injurious profiles of an enigmatic enzyme. , 1992, Biochemical medicine and metabolic biology.

[37]  R. Kondo,et al.  Ganoderic acid Df, a new triterpenoid with aldose reductase inhibitory activity from the fruiting body of Ganoderma lucidum. , 2010, Fitoterapia.

[38]  P. Zhou,et al.  Structural characterization and bioactivity evaluation of an acidic proteoglycan extract from Ganoderma lucidum fruiting bodies for PTP1B inhibition and anti-diabetes. , 2014, Biopolymers.

[39]  H. Hikino,et al.  Isolation and hypoglycemic activity of ganoderans A and B, glycans of Ganoderma lucidum fruit bodies. , 1985, Planta medica.

[40]  Ganoderma lucidum.  Ganoderma lucidum in cancer research , 2006 .

[41]  Marjana Tomic-Canic,et al.  Cellular and molecular basis of wound healing in diabetes. , 2007, The Journal of clinical investigation.

[42]  Jing Han,et al.  Ganoderma Lucidum Polysaccharide Accelerates Refractory Wound Healing by Inhibition of Mitochondrial Oxidative Stress in Type 1 Diabetes , 2012, Cellular Physiology and Biochemistry.

[43]  A. Sharma,et al.  Probing Lingzhi or Reishi medicinal mushroom Ganoderma lucidum (higher Basidiomycetes): a bitter mushroom with amazing health benefits. , 2013, International journal of medicinal mushrooms.

[44]  P. Zhou,et al.  A protein tyrosine phosphatase 1B activity inhibitor from the fruiting bodies of Ganoderma lucidum (Fr.) Karst and its hypoglycemic potency on streptozotocin-induced type 2 diabetic mice. , 2011, Journal of agricultural and food chemistry.

[45]  Bojana Boh,et al.  Ganoderma lucidum: a potential for biotechnological production of anti-cancer and immunomodulatory drugs. , 2013, Recent patents on anti-cancer drug discovery.

[46]  R. Kondo,et al.  5alpha-reductase inhibitory effect of triterpenoids isolated from Ganoderma lucidum. , 2006, Biological & pharmaceutical bulletin.

[47]  K. Kaestner,et al.  The diabetes gene Pdx1 regulates the transcriptional network of pancreatic endocrine progenitor cells in mice. , 2009, The Journal of clinical investigation.

[48]  B. Schwippert,et al.  Introduction of apoptosis by high proinsulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species. , 1998, Diabetologia.

[49]  R. Kondo,et al.  5α-Reductase Inhibitory Effect of Triterpenoids Isolated from Ganoderma lucidum(Miscellaneous) , 2006 .

[50]  H. Hikino,et al.  Mechanisms of hypoglycemic activity of ganoderan B: a glycan of Ganoderma lucidum fruit bodies. , 1989, Planta medica.

[51]  R. Paterson,et al.  Ganoderma - a therapeutic fungal biofactory. , 2006, Phytochemistry.

[52]  P. Cheng,et al.  Polysaccharides-Rich Extract of Ganoderma lucidum (M.A. Curtis:Fr.) P. Karst Accelerates Wound Healing in Streptozotocin-Induced Diabetic Rats , 2013, Evidence-based complementary and alternative medicine : eCAM.